Safety evaluation of whey derived beta-lactoglobulin, Lacprodan® BLG

The safety of Lacprodan® BLG, a whey-based protein, was evaluated with respect to genotoxicity and sub-chronic toxicity according to regulatory requirements. Lacprodan® BLG did not show any mutagenic potential in a bacterial reverse mutation assay or any clastogenic or aneugenic potential in an in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Dybdahl, Marianne, Selesko, David Benjamin, Mikkelsen, Ulla Ramer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010207/
https://www.ncbi.nlm.nih.gov/pubmed/33816124
http://dx.doi.org/10.1016/j.toxrep.2021.03.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010207/
https://www.ncbi.nlm.nih.gov/pubmed/33816124
http://dx.doi.org/10.1016/j.toxrep.2021.03.012

Ejemplares similares